Neeraj Agarwal Huntsman Cancer Center discusses Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:?Results of the dose-escalation stage in ?patients with treatment-naïve advanced ?renal cell carcinoma at the Seventeenth International Kidney Cancer International Symposium 2018 in Miami FL.
Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:?Results of the dose-escalation stage in ?patients with treatment-naïve advanced ?renal cell carcinoma
